Recent advances in biomedical research are rapidly shifting from single-method approaches toward multidimensional, data-driven strategies. As researchers seek to better understand complex biological systems, the importance of advanced research infrastructure continues to grow.
In this context, Dongguk University Medical Center's proposal to enhance its research infrastructure was selected for the national "Infrastructure Advancement Program" in June 2025, led by the Ministry of Education, National Research Foundation of Korea, and National Research Facilities & Equipment Center. This initiative aims to strengthen Korea's research capabilities by supporting the introduction of advanced equipment and the development of specialized personnel.
Revvity is proud to share the story of our collaboration with Dongguk University Center and our role in supporting this project.
Background and objectives
Dongguk University Medical Center emphasized the need for a next-generation research platform that integrates deep imaging-based omics analysis with high-throughput technologies. The institution was selected for the program based on this vision.
With its unique ecosystem combining academia, industry, research institutes, and hospitals, the center is well-positioned to serve as a key research hub in the northwestern Gyeonggi region.
In this interview, we spoke with Ji Wook Moon, who oversees the overall project, including equipment implementation and research support.
Professor Moon explained that the goal of the center is "not simply to introduce advanced equipment, but to establish a research ecosystem that connects basic research, clinical research, and drug discovery." He also highlighted the importance of enabling precise analysis of disease mechanisms and supporting the discovery of therapeutic targets, biomarkers, and new drug candidates.
Collaboration with Revvity
Dongguk University Medical Center identified Revvity's ability to provide an integrated platform-combining imaging-based analysis, high-content screening, and automation-as a key strength.
Rather than focusing solely on individual instrument performance, the decision was based on the value of a unified workflow that supports the broader research environment.
In addition, Revvity's software platform, Harmony, which enables AI-driven image and data analysis, is expected to support a wide range of research applications.
The team also noted that Revvity Korea’s technical support, application-focused consultation, and effective communication between researchers and engineers have contributed positively to establishing a strong foundation for long-term collaboration.
Research Platform Overview
The Innovation Medical Technology Center is currently equipped with two core integrated systems designed to support automated and imaging-based workflows.
The first system combines the Janus™ G3 Automated Workstation
JANUS G3 BioTx Pro Workstation
with the EnVision™ Nexus
EnVision Nexus Multimode Microplate Reader
multimode plate reader, forming a high-throughput screening platform. This configuration automates sample preparation, reagent dispensing, and analysis, helping to enable fast and reproducible in vitro experiments.
The second system features Opera Phenix™
Opera Phenix Plus High-Content Imaging System - Single Camera
Plus high content imaging system integrated with robotic arms and incubators. This platform supports long-term, large-scale cellular imaging and quantitative analysis under various experimental conditions.
Together, these systems provide a foundation for high-quality data generation and efficient experimental workflows.
Our commitment
As a long-term collaborator, Revvity is committed to supporting the sustainable operation and continued advancement of Dongguk University's Innovation Medical Technology Center.
Revvity will provide ongoing technical training and application support to help researchers maximize the value of their systems. In addition, we look forward to contributing to the center's growth as a leading automated research platform in Korea by sharing the latest technologies and fostering collaborative research opportunities that advance scientific discovery.
For research use only. Not for use in diagnostic procedures.
